UK-based Medvivo acquires clinical decision support app Expert 24

Medvivo

UK-based Medvivo has acquired Expert 24, a global developer of clinical decision support applications for some of the world’s largest healthcare providers, insurers and health information platforms including BUPA, AXA PPP Healthcare, U.S. Department of Veterans Affairs and WebMD.

The acquisition is expected to strengthen Medvivo’s range of clinical technology products and services built up over the past 11 years; and will support Expert 24’s continued growth throughout the US, UK and Europe. Also, it will provide job opportunities for UK-based developers seeking to pursue careers in creating digital solutions that improve essential healthcare services.

Founded in 2001, Expert 24 provides customized, trusted algorithms for some of the world’s largest healthcare providers, insurers and health information platforms. The company’s proprietary technology refines and integrates the most complex clinical algorithms and assessments to help its clients tackle acute and primary care challenges, and manage chronic conditions. Its population health and personal health risk management product helps providers to assess and better understand macro health risks as well as providing insights that can encourage individuals to change behaviors towards managing their health and well-being.

“Effective, patient-centric healthcare services rely on innovations that unlock efficiencies and plug skills shortages while empowering the people that use them,” Andrew Gardner, CEO of Medvivo, said in a statement. “To help meet this need, Medvivo is working to become the UK’s number one provider of digital healthcare products and services. Bringing such a successful and complementary operation as Expert 24 into our stable will deepen our offering, extend our reach internationally, and strengthen our ambition to improve the accessibility, quality, and cost-effectiveness of healthcare services.”

Financial terms of the acquisition were not disclosed.